Nautilus Biotechnology (NAUT)'s 30-day implied volatility (IV30) was 142.1% at the close on October 20, 2026, up from 133.3% the day before, against a 52-week range of 60.1% to 216.7%. Its 20-day historical volatility was 187.7%.
Data as of October 20, 2026.